5L3

(6R)-5-O-acetyl-2,6-anhydro-6-{[4-(sulfamoyloxy)piperidin-1-yl]sulfonyl}-L-glucitol

Created:	2015-10-16
Last modified:	2020-07-17

Find Related PDB Entry
1 entries where 5L3 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	52
Chiral Atom Count	5
Bond Count	53
Aromatic Bond Count	0

2D diagram of 5L3

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(6R)-5-O-acetyl-2,6-anhydro-6-{[4-(sulfamoyloxy)piperidin-1-yl]sulfonyl}-L-glucitol
Systematic Name (OpenEye OEToolkits)	[(2R,3R,4R,5R,6R)-6-(hydroxymethyl)-4,5-bis(oxidanyl)-2-(4-sulfamoyloxypiperidin-1-yl)sulfonyl-oxan-3-yl] ethanoate
Formula	C₁₃ H₂₄ N₂ O₁₁ S₂
Molecular Weight	448.466
Type	D-SACCHARIDE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C1(C(OC(C)=O)C(O)C(C(CO)O1)O)S(=O)(=O)N2CCC(CC2)OS(=O)(=O)N
SMILES	CACTVS	3.385	CC(=O)O[CH]1[CH](O)[CH](O)[CH](CO)O[CH]1[S](=O)(=O)N2CC[CH](CC2)O[S](N)(=O)=O
SMILES	OpenEye OEToolkits	1.9.2	CC(=O)OC1C(C(C(OC1S(=O)(=O)N2CCC(CC2)OS(=O)(=O)N)CO)O)O
Canonical SMILES	CACTVS	3.385	CC(=O)O[C@@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1[S](=O)(=O)N2CC[C@@H](CC2)O[S](N)(=O)=O
Canonical SMILES	OpenEye OEToolkits	1.9.2	CC(=O)O[C@@H]1[C@@H]([C@H]([C@H](O[C@@H]1S(=O)(=O)N2CCC(CC2)OS(=O)(=O)N)CO)O)O
InChI	InChI	1.03	InChI=1S/C13H24N2O11S2/c1-7(17)24-12-11(19)10(18)9(6-16)25-13(12)27(20,21)15-4-2-8(3-5-15)26-28(14,22)23/h8-13,16,18-19H,2-6H2,1H3,(H2,14,22,23)/t9-,10+,11-,12-,13-/m1/s1
InChIKey	InChI	1.03	YXPKUHUEEVWRKJ-NZEXEKPDSA-N

Related Resource References

Resource Name	Reference
PubChem	91971380

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.